Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Fanbin Hu"'
Autor:
Tongmei Zhang, Lina Zhang, Yuan Gao, Ying Wang, Yanxia Liu, Hongmei Zhang, Qunhui Wang, Fanbin Hu, Jie Li, Jinjing Tan, Daisy Dandan Wang, Olivier Gires, Peter Ping Lin, Baolan Li
Publikováno v:
Molecular Oncology, Vol 15, Iss 11, Pp 2891-2909 (2021)
Prognosticating the efficacy of anti‐angiogenic therapy through longitudinal monitoring and early detection of treatment resistance in cancer patients remain highly challenging. In this study, co‐detection and comprehensive phenotypic and karyoty
Externí odkaz:
https://doaj.org/article/25e5cf5fcef84a67b539d56385114b3d
Autor:
Ying WANG, Yi GUO, Haifeng LIN, Lina ZHANG, Hongmei ZHANG, Qunhui WANG, Fanbin HU, Jie LI, Baolan LI, Tongmei ZHANG
Publikováno v:
Chinese Journal of Lung Cancer, Vol 24, Iss 8, Pp 583-590 (2021)
Background and objective Small cell lung cancer (SCLC) is a highly aggressive malignancy characterized by rapid growth, early metastasis and acquired therapeutic resistance, and the prognosis is extremely poor. Studies have proved that the stem cell
Externí odkaz:
https://doaj.org/article/9eaf84208d634deaa13266ec79f7a12b
Autor:
Yanxia LIU, Tongmei ZHANG, Yuan GAO, Yang QU, Baohua LU, Hongmei ZHANG, Qunhui WANG, Jie LI, Fanbin HU, Baolan LI
Publikováno v:
Chinese Journal of Lung Cancer, Vol 22, Iss 11, Pp 687-695 (2019)
Background and objective In recent years, a number of clinical trials have shown that immunocheckpoint inhibitors (ICI) have brought survival benefits to patients with advanced non-small cell lung cancer (NSCLC), however, such clinical trials compris
Externí odkaz:
https://doaj.org/article/cd225116f601477ca0dfaccded0fc772
Autor:
Qunhui WANG, Hua ZHENG, Fanbin HU, Hongmei ZHANG, Ying HU, Jie LI, Tongmei ZHANG, Zan LIU, Baohua LU, Aimin HU, Baolan LI
Publikováno v:
Chinese Journal of Lung Cancer, Vol 19, Iss 8, Pp 550-558 (2016)
Background and objective Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are the standard first-line treatment regimen for EGFR mutated non-small cell lung cancer (NSCLC) patients. However, the efficacy of EGFR-TKIs widely var
Externí odkaz:
https://doaj.org/article/65650ec20af641c59eac188b8a189d1c
Autor:
Haiyong WANG, Yanfei GU, Xi LI, Xinjie YANG, Fanbin HU, Qunhui WANG, Shucai ZHANG, Jinghui ZHANG
Publikováno v:
Chinese Journal of Lung Cancer, Vol 11, Iss 1, Pp 110-114 (2008)
Background and objective Docetaxel is an active agent in the second-line treatment for non-small cell lung cancer (NSCLC), many clinical trials have demonstrated that it has similar efficacy to common first-line regimens for NSCLC. A randomized study
Externí odkaz:
https://doaj.org/article/bd9681587c42410f9f30552f4d47cd44
Autor:
Tongmei Zhang, Qunhui Wang, Fanbin Hu, Baolan Li, Jie Li, Hongmei Zhang, Mingming Hu, Meng Gu, Yuan Yang
Publikováno v:
Genetic Testing and Molecular Biomarkers. 24:798-803
Background: Hypoxia inducible factor-1α (HIF-1α) and vascular endothelial growth factor (VEGF) are key angiogenic regulatory factors. The aim of this study was to identify the most useful prognosti...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53d77b8346fe56e6153fc00edf53b997
https://doi.org/10.1089/gtmb.2020.0173
https://doi.org/10.1089/gtmb.2020.0173
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d412f65f066e7455d3f64be77cd91317
https://doi.org/10.2139/ssrn.4258695
https://doi.org/10.2139/ssrn.4258695
Autor:
Li Tong, Baolan Li, Peter Lin, Yanxia Liu, Yuan Gao, Fanbin Hu, Ying Wang, Tongmei Zhang, Lina Zhang
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Objective To investigate the presence of vimentin expression in CTCs and its clinical relevance in patients with advanced lung cancer. Methods Peripheral blood was obtained from 61 treatment-naive patients with advanced lung cancer. Subtraction enric
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3831389043a7c73f457e795bec09dec7
https://pubmed.ncbi.nlm.nih.gov/31646374
https://pubmed.ncbi.nlm.nih.gov/31646374
Autor:
Xuebing Li, Hongmei Zhang, Yuan Yang, Aimin Hu, Qunhui Wang, Tongmei Zhang, Jie Li, Baolan Li, Heling Shi, Wentao Yue, Yuan Gao, Zan Liu, Baohua Lu, Haiqing Zhang, Fanbin Hu
Publikováno v:
Cell Biochemistry and Biophysics. 73:631-637
The prognostic role of phosphatase and tensin homolog (PTEN) in non-small cell lung cancer (NSCLC) has been controversial. In this study, levels of PTEN expression were investigated in NSCLC patients and their prognostic value in NSCLC was assessed.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f6e0e1d470f76026f95fe479131c763
https://doi.org/10.1007/s12013-015-0671-z
https://doi.org/10.1007/s12013-015-0671-z
Publikováno v:
Thoracic Cancer. 5:358-361
Many studies have illustrated that two types of mutation – deletions in exon 19 and a point mutation in exon 21 (L858R) – have been reported to comprise up to 90% of all activating epidermal growth factor receptor (EGFR) mutations. A point mutati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1925ef26c26bd27a7d74d771b90d8d96
https://doi.org/10.1111/1759-7714.12096
https://doi.org/10.1111/1759-7714.12096